Unexpectedly High Incidence of Immune‐Related Adverse Events in Gastric Cancer Patients Who Received Conversion Surgery After Nivolumab‐Including Chemotherapy
IrAE was frequently observed not only during chemotherapy but also during perioperative period. Surgeons must pay special attention to unfamiliar irAE events during perioperative period.
Authors
- Mayuko Takuwa
- Yasuyuki Seto (ORCID: https://orcid.org/0000-0002-6953-8752)
- Takaki Yoshikawa (ORCID: https://orcid.org/0000-0003-1936-9484)
- Rei Ogawa (ORCID: https://orcid.org/0000-0003-3658-555X)
- Nobuyoshi Hiraoka (ORCID: https://orcid.org/0000-0003-4215-4385)
- Yuki Takenaka
- Yukinori Yamagata (ORCID: https://orcid.org/0000-0003-2624-1251)
- Hirokazu Shoji
- Tsutomu Hayashi (ORCID: https://orcid.org/0000-0002-9193-8269)
- Yurina Fujisaki
- Takeyuki Wada (ORCID: https://orcid.org/0000-0003-3407-7981)
- Masashi Nishino (ORCID: https://orcid.org/0009-0000-4612-9537)
Institutions
- Jikei University School of Medicine (JP)
- National Cancer Center Hospital East (JP)
- Tokyo National Hospital (JP)
Publication Details
- Journal
- Annals of Gastroenterological Surgery
- Published
- 2025-10-26
- DOI
- https://doi.org/10.1002/ags3.70103
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00